Docket Number:10A-981210
Inventor:Jyh-Yih Chen, Chieh-Yu Pan
IP Status:TW I394579
Abstract:
Even though antimicrobial peptides (AMPs) are effective against a wide range of microbes, their use in duck disease therapy has not been reported yet. Riemerella anatipestifer (Ra) is a gram-negative bacterium which infects ducks and causes sever economic losses. We show that pretreatment, co-treatment, and post-treatment with peptides are all effective in decreasing the number of infectious bacteria and duck mortality after bacterial challenge. This result suggests that peptides have the potential to serve as therapeutic drugs for use against bacterial infectious diseases in ducks.
Fields of Application:
In this application, we investigated the effects of synthesized epinecidin-1, anti-LPS factor, and hepcidin peptides on Ra-induced sepsis in ducks. Our results show that epinecidin-1, hepcidin, and the anti-LPS factor are attractive candidates for development as therapeutic drugs for use against microbial infection in duck Ra epidemiology.
Advantages when compared to the existing technologies:
As is known, vaccinations against Ra infection utilize bacterins and are usually made from formalin-killed preparations of the organism. This method was not efficacious due to unacceptably toxicity, incomplete protection, and its short-lived nature. A more-advanced method for effectively protecting ducks used vaccines produced by live, attenuated organisms. But live vaccines are not acceptable to authorities responsible for vaccine licensing, and Ra recovered from ducks can adversely affect growth, although live attenuated vaccines stimulate protracted cell-mediated immunity and antibody responses. In the present study, after treatment with CA, LA, EPI, TH1-5, and TH2-3, the Ra outer membrane was uneven and disrupted which led to leakage of the intracellular contents precipitating cell death. Bacterial debris may stimulate the duck antibody response as antigens and protect ducks from a second Ra challenge.
Contact Person:
對本技術有興趣,請於本處網頁廠商選項下(廠商需求與諮詢)網頁填寫資料,承辦人將跟您聯絡。
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Apply for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office, and the undertaker will contact you.
